Penumbra, Inc.
(NYSE : PEN)

( )
PEN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.54%580.801.0%$817.23m
DHRDanaher Corp. -0.59%285.310.7%$631.56m
ISRGIntuitive Surgical, Inc. -2.61%232.880.8%$506.40m
ABTAbbott Laboratories -0.96%107.950.8%$472.87m
MDTMedtronic Plc -0.50%93.110.6%$415.10m
SYKStryker Corp. -1.09%214.951.3%$366.31m
BSXBoston Scientific Corp. 0.15%41.031.0%$306.78m
EWEdwards Lifesciences Corp. -3.82%101.440.4%$250.54m
ALGNAlign Technology, Inc. -6.63%273.646.4%$247.16m
DXCMDexCom, Inc. -6.87%85.121.9%$242.21m
BDXBecton, Dickinson & Co. -0.27%255.281.0%$221.09m
IDXXIDEXX Laboratories, Inc. -4.52%388.603.8%$216.95m
BAXBaxter International, Inc. -1.26%58.961.8%$189.90m
AAgilent Technologies, Inc. -2.75%128.871.7%$168.64m
MTDMettler-Toledo International, Inc. -1.99%1315.405.9%$150.23m

Company Profile

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. Its target markets include interventional neuroradiologists, neurosurgeons, neurologists, cardiologists, radiologists, and vascular surgeons. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.